Effect of cyclosporine withdrawal on IL-10 production in kidney transplant recipients.
Alberú
J
J
Department of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. donevida@quetzal.innsz.mx
Richaud-Patin
Y
Y
Mancilla
E
E
Díliz
H
H
Correa-Rotter
R
R
Chew-Wong
A
A
Uribe
N
N
de Leo
C
C
Llorente
L
L
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage; D006084:Graft Rejection / Q000139:chemically induced* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016753:Interleukin-10 / Q000378:metabolism*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D013375:Substance Withdrawal Syndrome / Q000276:immunology / Q000378:metabolism*
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D016753:Interleukin-10; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone